The mutation spectrum of the lad gene from the liver of C57B16 Big Blue(R)
transgenic mice treated with benzo[a]pyrene (B[a]P) has been compared with
the spectrum of spontaneous mutations observed in the liver of untreated Bi
g Blue(R) mice, Mice were treated with B[a]P for 3 days followed by a parti
al hepatectomy one day after the last injection. Liver tissue was removed f
or analysis at hepatectomy and, again, 3 days later at the time of sacrific
e. Earlier, we reported that the lacI mutant frequency in these B[a]P-treat
ed mice was elevated in the liver both at the time of hepatectomy and at sa
crifice; however, a statistically significant increase in the mutant freque
ncy was observed only at sacrifice. In this study, the DNA sequence spectra
of lad mutations observed in the liver of B[a]P-treated Big Blue(R) mice a
t hepatectomy and at time of sacrifice were compared with each other and wi
th the spectrum of spontaneous liver mutations. No differences were observe
d between the two B[a]P-treatment spectra, However, mutation frequencies of
both GC->TA and GC->CG at the time of hepatectomy and at sacrifice were si
gnificantly elevated compared with the spontaneous frequency of these same
transversions, Also, the frequency of AT->TA transversions was significantl
y higher than the spontaneous frequency at the time of hepatectomy but not
at sacrifice. The frequency of all other classes of mutations scored was no
t significantly different from the frequency of these same events in the sp
ontaneous spectra, These data support the view that B[a]P treatment results
in the induction of GC->TA and GC->CG transversions within 1 day of the la
st injection and they provide insights regarding the relative roles of benz
o[a]pyrene-7,8-diol-9,10-epoxide and radical cations of B[a]P in B[a]P-indu
ced mutagenesis in vivo. Finally, these data provide evidence for B[a]P-ind
uced mutagenesis under conditions where no statistical increase in mutant f
requency could be shown.